Table 1.
Aggregate clinical data for VL patients and Endemic controls
| VL (pre-treatinent)A | VL (post-treatment) | EC | control spleen | ||
|---|---|---|---|---|---|
| n | 100 | 39 | 29 | 10 | |
| Age | 25.91 ± 15.2(25)B | 27 ± 13.4(25) | 33.5 ± 9.2(35) | ND | |
| Sex (M/F) | 64/36 | 25/14 | 18/11 | ND | |
| Duration of illness (days) | 24.3 ± 30.3(15) | 27.2 ± 23.2(20) | N/A | NA | |
| Infection scoreC Day 0 | 2 ± 1.1(2) | 1.92 ± 1(2) | N/A | N/A | |
| Day dis | 0 | 0 | NA | NA | |
| N/A | N/A | ||||
| Spleen size (cm) Day 0 | 4.8 ± 3.9(3) | 4.8 ± 3.3(4) | |||
| Day dis | 0.57 ± 1.3 | 0.8 ± 1.6 | N/A | N/A | |
| WBC(X103/mm3) Day 0 | 3.2 ± 1.3(3) | 3.1 ± 0.9(3) | ND | ND | |
| Day dis | 7 ± 2.3(7) | 6.3 ± 2.1(6.2) | ND | N/A | |
N/D, not done: N/A, not applicable.
A
Includes 39 donors from whom post-treatment samples were also available
B
Mean values ± SD of aggregated data are shown, median values are in parenthesis.
C
Scoring of parasite load is on a logarithmic scale from 1 to 6, were 0 is no parasites per 1,000 microscopic fields (1,000X), 1 is 1–10 parasites per 1,000 fields, and 6 is >100 parasites per field.